<DOC>
	<DOCNO>NCT01980550</DOCNO>
	<brief_summary>Nicotine replacement treatment ( NRT ) efficacious smoke cessation , use minority smoker China . Pharmacogenetic matching may improve treatment outcome NRT subgroups smoker . The investigator evaluate efficacy safety sublingual nicotine tablet ( SNT ) smoke cessation association catechol-O-methyltransferase ( COMT ) genotype efficacy smoke cessation trial among Chinese smoker .</brief_summary>
	<brief_title>Association Functional COMT Val108/Met Polymorphism With Smoking Cessation Nicotine Replacement Therapy</brief_title>
	<detailed_description>All subject provide write informed consent full explanation protocol design .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subjects motivate stop smoking Han Chinese age 2070 year live Haidian District Beijing smoke ≥10 cigarettes/day smoke ≥3 year carbon monoxide ( CO ) level ≥10 p.p.m . exhale air history `` Diagnostic Statistical Manual Mental Disorders—fourth Edition '' ( DSMIV ) psychiatric disorder alcohol abuse drug abuse pathological change floor mouth cardiovascular disease take psychotropic medication use form tobacco NRT product last 6 month pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>